Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × NET × Clear all

Phase

Status

Completed 19 Recruiting 8 Terminated 6 Withdrawn 2 Unknown 2 Not yet recruiting 2 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 138 Gastrointestinal 60 Thoracic 52 Lymphoid 40 Breast 37 Genitourinary 33 Other hematologic neoplasm 30 Dermatologic 28 Head & Neck 26 Gynecologic 21 CNS 21 Sarcoma 12 Plasma cell 10 Myeloid 10 Other 5 Endocrine 5 Other solid neoplasm 3 Classical hematology 3 Other neoplasm 2 NET 1

Conditions

Neuroendocrine Tumors 41 Gastro-enteropancreatic neuroendocrine tumor 9 Carcinoma, Neuroendocrine 5 Small Cell Lung Carcinoma 4 Colorectal Neoplasms 4 Cholangiocarcinoma 4 Carcinoid Tumor 4 Thyroid Neoplasms 3 Carcinoma, Hepatocellular 3 Biliary Tract Neoplasms 3 Adenoma, Islet Cell 3 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Sarcoma 2 Salivary Gland Neoplasms 2 Pheochromocytoma 2 Paraganglioma 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasms, Unknown Primary 2 Mesothelioma 2 Carcinoma, Merkel Cell 2 Carcinoma, Medullary 2 Brain Neoplasms 2 Anus Neoplasms 2 Adrenal Gland Neoplasms 2 Vipoma 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06502977 2025-10-28

DeLLphi-307

Amgen

Phase 2 Active not recruiting

Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡